Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors despite daily gains


Shares of Becton Dickinson & Co.
BDX,
+1.05%
inched 0.36% higher to $249.35 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index
SPX,
+0.28%
falling 0.20% to 4,343.54 and Dow Jones Industrial Average
DJIA,
+0.37%
falling 0.60% to 34,577.37. This was the stock’s third consecutive day of gains. Becton Dickinson & Co. closed $35.62 short of its 52-week high ($284.97), which the company reached on August 5th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Thermo Fisher Scientific Inc.
TMO,
+0.67%
rose 0.73% to $517.06, Intuitive Surgical Inc.
ISRG,
+0.83%
rose 1.05% to $948.04, and Baxter International Inc.
BAX,
+4.84%
fell 0.84% to $81.07. Trading volume (1.0 M) remained 412,753 below its 50-day average volume of 1.5 M.


Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.


View more information: https://www.marketwatch.com/story/becton-dickinson-co-stock-underperforms-tuesday-when-compared-to-competitors-despite-daily-gains-01625603999-ffe792a24f57

Articles in category: moneyist
See also  Civil liberties groups are suing the SEC, saying policy of ‘no admit, no deny’ is unconstitutional

Leave a Reply

Back to top button